Table 1.
Group | Sex, M | Age (Median, IQR) |
Neurogranin, pg/mL (Median, IQR) |
---|---|---|---|
AD (n = 33) | 52% | 71 (66–77) | 401 (270–521) |
Cerebrovascular diseases (n = 12) | 75% | 60 (52–67) | 114 (58–281) |
Inflammatory CNS diseases (n = 10) | 30% | 64 (58–76) | 200 (76–303) |
Peripheral Neuropathy (n = 41) | 61% | 60 (48–71) | 260 (89–352) |
Other neurological diseases (n = 7) | 43% | 63 (48–72) | 163 (38–338) |
Controls (n = 33) | 58% | 52 (39–67) | 109 (54–373) |
AD, Alzheimer’s disease; CNS, central nervous system; M, male sex; IQR, inter quartile range.